Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours

被引：0
|
作者：
S. A. Veltkamp
H. Rosing
A. D. R. Huitema
M. R. Fetell
A. Nol
J. H. Beijnen
J. H. M. Schellens
机构：
[1] The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital,Division of Experimental Therapy
[2] The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital,Department of Medical Oncology
[3] The Netherlands Cancer Institute/Slotervaart Hospital,Department of Pharmacy and Pharmacology
[4] University of Utrecht,Division of Biomedical Analysis, Faculty of Pharmaceutical Sciences
[5] Ivax Research,undefined
[6] Inc.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Phase I; Pharmacokinetics; Paclitaxel; Cremophor-free; Oral administration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：635 / 642
页数：7
相关论文
共 50 条
  • [21] A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application
    Veltkamp, S. A.
    Alderden-Los, C.
    Sharma, A.
    Rosing, H.
    Beijnen, J. H.
    Schellens, J. H. M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) : 43 - 50
  • [22] A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application
    S. A. Veltkamp
    C. Alderden-Los
    A. Sharma
    H. Rosing
    J. H. Beijnen
    J. H. M. Schellens
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 43 - 50
  • [23] Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours
    Martin, L. P.
    Kozloff, M. F.
    Herbst, R. S.
    Samuel, T. A.
    Kim, S.
    Rosbrook, B.
    Tortorici, M.
    Chen, Y.
    Tarazi, J.
    Olszanski, A. J.
    Rado, T.
    Starr, A.
    Cohen, R. B.
    BRITISH JOURNAL OF CANCER, 2012, 107 (08) : 1268 - 1276
  • [24] Phase I clinical and pharmacokinetic study of trablectedin and cisplatin in solid tumours
    Sessa, C.
    Cresta, S.
    Noberasco, C.
    Capri, G.
    Gallerani, E.
    De Braud, F.
    Zucchetti, M.
    D'Incalci, M.
    Locatelli, A.
    Marsoni, S.
    Corradino, I.
    Minoia, C.
    Zintl, P.
    Gianni, L.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (12) : 2116 - 2122
  • [25] Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours
    L P Martin
    M F Kozloff
    R S Herbst
    T A Samuel
    S Kim
    B Rosbrook
    M Tortorici
    Y Chen
    J Tarazi
    A J Olszanski
    T Rado
    A Starr
    R B Cohen
    British Journal of Cancer, 2012, 107 : 1268 - 1276
  • [26] Phase I pharmacokinetic and sequence finding study of the combination of docetaxel and methotrexate in patients with solid tumours
    Louwerens, M
    Smorenburg, C
    Sparreboom, A
    Loos, WJ
    Verweij, J
    de Wit, R
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (04) : 497 - 504
  • [27] Phase 1a safety and pharmacokinetic study of oral NV-196 in patients with solid tumours
    Mainwaring, P. N.
    West, L.
    Husband, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
    M Harries
    A O'Donnell
    M Scurr
    S Reade
    C Cole
    I Judson
    A Greystoke
    C Twelves
    S Kaye
    British Journal of Cancer, 2004, 91 : 1651 - 1655
  • [29] Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
    Kaye, S.
    Aamdal, S.
    Jones, R.
    Freyer, G.
    Pujade-Lauraine, E.
    de Vries, E. G. E.
    Barriuso, J.
    Sandhu, S.
    Tan, D. S-W
    Hartog, V.
    Kuenen, B.
    Ruijter, R.
    Kristensen, G. B.
    Nyakas, M.
    Barrett, S.
    Burke, W.
    Pietersma, D.
    Stuart, M.
    Emeribe, U.
    Boven, E.
    BRITISH JOURNAL OF CANCER, 2012, 106 (11) : 1728 - 1734
  • [30] Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
    S Kaye
    S Aamdal
    R Jones
    G Freyer
    E Pujade-Lauraine
    E G E de Vries
    J Barriuso
    S Sandhu
    D S-W Tan
    V Hartog
    B Kuenen
    R Ruijter
    G B Kristensen
    M Nyakas
    S Barrett
    W Burke
    D Pietersma
    M Stuart
    U Emeribe
    E Boven
    British Journal of Cancer, 2012, 106 : 1728 - 1734
12345